Cargando…
Alpha-Galacto-Oligosaccharides at Low Dose Improve Liver Steatosis in a High-Fat Diet Mouse Model
Non-Alcoholic Fatty Liver Disease (NAFLD) is the major liver disease worldwide and is linked to the development of metabolic syndrome and obesity. As alpha-galacto-oligosaccharides (α-GOS) from legumes have been shown to reduce body weight and hyperphagia in overweight adults, it was hypothesized th...
Autores principales: | Chappuis, Eric, Morel-Depeisse, Fanny, Bariohay, Bruno, Roux, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151545/ https://www.ncbi.nlm.nih.gov/pubmed/29036913 http://dx.doi.org/10.3390/molecules22101725 |
Ejemplares similares
-
Galacto-oligosaccharides and bowel function
por: Niittynen, Leena, et al.
Publicado: (2007) -
The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut
por: Arnold, Jason W., et al.
Publicado: (2021) -
Biological activity of galacto-oligosaccharides: A review
por: Mei, Zhaojun, et al.
Publicado: (2022) -
Fermentation properties and potential prebiotic activity of Bimuno(®) galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters
por: Grimaldi, Roberta, et al.
Publicado: (2016) -
Safety and Modulatory Effects of Humanized Galacto-Oligosaccharides on the Gut Microbiome
por: Arnold, Jason W., et al.
Publicado: (2021)